Penumbra (PEN) Competitors $300.50 +2.25 (+0.75%) Closing price 04/25/2025 03:59 PM EasternExtended Trading$303.50 +3.00 (+1.00%) As of 04/25/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock PEN vs. GEHC, PHG, ZBH, SNN, SOLV, STVN, GKOS, NARI, INSP, and BLCOShould you be buying Penumbra stock or one of its competitors? The main competitors of Penumbra include GE HealthCare Technologies (GEHC), Koninklijke Philips (PHG), Zimmer Biomet (ZBH), Smith & Nephew (SNN), Solventum (SOLV), Stevanato Group (STVN), Glaukos (GKOS), Inari Medical (NARI), Inspire Medical Systems (INSP), and Bausch + Lomb (BLCO). These companies are all part of the "medical equipment" industry. Penumbra vs. GE HealthCare Technologies Koninklijke Philips Zimmer Biomet Smith & Nephew Solventum Stevanato Group Glaukos Inari Medical Inspire Medical Systems Bausch + Lomb Penumbra (NYSE:PEN) and GE HealthCare Technologies (NASDAQ:GEHC) are both large-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, community ranking, risk, institutional ownership, valuation, media sentiment, earnings, analyst recommendations and dividends. Which has preferable earnings & valuation, PEN or GEHC? GE HealthCare Technologies has higher revenue and earnings than Penumbra. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPenumbra$1.19B9.73$90.95M$0.34883.82GE HealthCare Technologies$19.67B1.59$1.99B$4.3315.80 Does the media refer more to PEN or GEHC? In the previous week, Penumbra had 15 more articles in the media than GE HealthCare Technologies. MarketBeat recorded 42 mentions for Penumbra and 27 mentions for GE HealthCare Technologies. GE HealthCare Technologies' average media sentiment score of 1.18 beat Penumbra's score of 1.00 indicating that GE HealthCare Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Penumbra 19 Very Positive mention(s) 2 Positive mention(s) 11 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive GE HealthCare Technologies 16 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community prefer PEN or GEHC? Penumbra received 812 more outperform votes than GE HealthCare Technologies when rated by MarketBeat users. Likewise, 80.36% of users gave Penumbra an outperform vote while only 61.36% of users gave GE HealthCare Technologies an outperform vote. CompanyUnderperformOutperformPenumbraOutperform Votes83980.36% Underperform Votes20519.64%GE HealthCare TechnologiesOutperform Votes2761.36% Underperform Votes1738.64% Which has more volatility & risk, PEN or GEHC? Penumbra has a beta of 0.56, indicating that its share price is 44% less volatile than the S&P 500. Comparatively, GE HealthCare Technologies has a beta of 1.14, indicating that its share price is 14% more volatile than the S&P 500. Do analysts prefer PEN or GEHC? Penumbra currently has a consensus price target of $302.40, suggesting a potential upside of 0.63%. GE HealthCare Technologies has a consensus price target of $96.50, suggesting a potential upside of 41.04%. Given GE HealthCare Technologies' higher probable upside, analysts clearly believe GE HealthCare Technologies is more favorable than Penumbra.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Penumbra 0 Sell rating(s) 3 Hold rating(s) 13 Buy rating(s) 1 Strong Buy rating(s) 2.88GE HealthCare Technologies 1 Sell rating(s) 2 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 2.77 Do institutionals & insiders have more ownership in PEN or GEHC? 88.9% of Penumbra shares are owned by institutional investors. Comparatively, 82.1% of GE HealthCare Technologies shares are owned by institutional investors. 5.0% of Penumbra shares are owned by company insiders. Comparatively, 0.3% of GE HealthCare Technologies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Is PEN or GEHC more profitable? GE HealthCare Technologies has a net margin of 10.13% compared to Penumbra's net margin of 1.17%. GE HealthCare Technologies' return on equity of 25.74% beat Penumbra's return on equity.Company Net Margins Return on Equity Return on Assets Penumbra1.17% 9.74% 7.35% GE HealthCare Technologies 10.13%25.74%6.29% SummaryPenumbra beats GE HealthCare Technologies on 10 of the 18 factors compared between the two stocks. Get Penumbra News Delivered to You Automatically Sign up to receive the latest news and ratings for PEN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PEN vs. The Competition Export to ExcelMetricPenumbraSurgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$11.62B$4.29B$5.44B$18.91BDividend YieldN/A46.48%5.43%4.13%P/E Ratio883.8230.2922.1432.57Price / Sales9.7352.50389.7028.52Price / Cash105.0151.0838.2017.53Price / Book10.066.096.664.45Net Income$90.95M$67.60M$3.21B$1.02B7 Day Performance8.63%4.51%6.21%3.51%1 Month Performance9.22%-7.02%-2.82%-4.90%1 Year Performance47.01%27.14%16.44%4.62% Penumbra Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PENPenumbra4.0159 of 5 stars$300.50+0.8%$302.40+0.6%+46.2%$11.62B$1.19B883.823,900Earnings ReportAnalyst ForecastInsider TradeAnalyst RevisionNews CoverageGEHCGE HealthCare Technologies4.5048 of 5 stars$60.48-3.0%$97.27+60.8%-20.4%$27.69B$19.67B13.9750,000Upcoming EarningsAnalyst ForecastOptions VolumeNews CoveragePositive NewsGap UpPHGKoninklijke Philips2.7117 of 5 stars$23.31-1.3%N/A+20.9%$21.91B$18.02B-27.7578,200Short Interest ↑Positive NewsZBHZimmer Biomet4.6972 of 5 stars$96.38-1.6%$124.15+28.8%-15.3%$19.07B$7.68B21.6618,000Positive NewsSNNSmith & Nephew1.9306 of 5 stars$25.71-0.8%$27.00+5.0%+11.6%$11.24B$5.81B11.9020,100Analyst DowngradeNews CoveragePositive NewsSOLVSolventum1.4496 of 5 stars$64.08-3.3%$79.86+24.6%+6.9%$11.09B$8.25B23.3022,000Positive NewsSTVNStevanato Group0.8583 of 5 stars€21.65-1.0%N/A-22.0%$6.56B$1.10B46.064,650News CoveragePositive NewsGKOSGlaukos4.6465 of 5 stars$88.17-2.3%$156.17+77.1%-3.5%$4.99B$383.48M-30.72780Upcoming EarningsNARIInari Medical0.6046 of 5 stars$79.97flat$68.00-15.0%N/A$4.68B$493.63M-59.24800Upcoming EarningsPositive NewsINSPInspire Medical Systems4.7673 of 5 stars$144.74-3.6%$218.90+51.2%-31.2%$4.31B$802.80M83.67760Positive NewsGap UpBLCOBausch + Lomb3.7997 of 5 stars$12.05-0.1%$18.82+56.2%-7.0%$4.26B$4.79B-13.2412,500Upcoming EarningsAnalyst ForecastGap Up Related Companies and Tools Related Companies GE HealthCare Technologies Competitors Koninklijke Philips Competitors Zimmer Biomet Competitors Smith & Nephew Competitors Solventum Competitors Stevanato Group Competitors Glaukos Competitors Inari Medical Competitors Inspire Medical Systems Competitors Bausch + Lomb Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:PEN) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | SponsoredTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump announcement boosts “next Bitcoin”President Trump just made his first big crypto move ... Announcing the creation of a national strategic re...Weiss Ratings | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Penumbra, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Penumbra With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PEN Stock Free PEN Stock Alerts